Practical considerations and guidelines for the management of community-acquired pneumonia

Drugs

Volumn 55, Issue 1, 1998, Pages 31-45

  Finch, Roger G ^a   Woodhead, Mark A ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; MACROLIDE;

ARTICLE; DISEASE SEVERITY; FLUID BALANCE; GAS EXCHANGE; HUMAN; MORTALITY; PNEUMONIA; PRACTICE GUIDELINE; STREPTOCOCCUS PNEUMONIAE; TREATMENT FAILURE;

ADULT; AGED; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; HOSPITALIZATION; HUMANS; PNEUMONIA; PNEUMONIA, STAPHYLOCOCCAL; PRACTICE GUIDELINES;

STREPTOCOCCUS PNEUMONIAE;

EID: 0031963475     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199855010-00003     Document Type: Article

References (62)

1. Melbye H, Berdal BP, Straume B, et al. Pneumonia - a clinical or radiographic diagnosis. Scand J Infect Dis 1992; 24: 647-55
2. Woodhead MA, Macfarlane JT, McCracken JS, et al. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet 1987; I: 671-4
3. Jokinen C, Heiskanen L, Juvonen H, et al. Incidence of community-acquired pneumonia in the population of four municipalities in Eastern Finland. Am J Epidemiol 1993; 137: 977-88
4. Koivula I, Sten M, Makela PH. Risk factors for pneumonia in the elderly. Am J Med 1994; 96: 313-20
5. Macfarlane JT, Finch RG, Ward MJ, et al. Hospital study of adult community-acquired pneumonia. Lancet 1982; II: 255-8
6. British Thoracic Society. Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors, and outcome. Q J Med 1987; 62: 195-220
7. Fang G-D, Fine M, Orloff J, et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy: a prospective multicenter study of 359 cases. Medicine 1990; 69: 307-16
8. Mundy LM, Auwaerter PG, Oldach D, et al. Community-acquired pneumonia: impact of immune status. Am J Respir Crit Care Med 1995; 152: 1309-15
9. Marrie TJ, Durant H, Yates L. Community-acquired pneumonia requiring hospitalisation: 5 year prospective study. Rev Infect Dis 1989; 11: 586-99
10. Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia. JAMA 1996; 275: 134-41
11. Almirall J, Morato I, Riera F, et al. Incidence of community acquired pneumonia and Chlamydia pneumoniae infection: a prospective multicentre study. Eur Respir J 1993; 6: 14-8
12. Marrie TJ, Peeling RW, Fine MJ, et al. Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. Am J Med 1996; 101: 508-15
13. Berntsson E, Lagergard T, Strannegard O, et al. Etiology of community-acquired pneumonia in outpatients. Eur J Clin Microbiol 1986; 5: 446-7
14. Ausina V, Coll P, Sambeat M, et al. Prospective study on the etiology of community-acquired pneumonia in children and adults in Spain. Eur J Clin Microbiol Infect Dis 1988; 7: 343-7
15. Berntsson H, Blomberg J, Lagergard T, et al. Etiology of community-acquired pneumonia in patients requiring hospitalisation. Eur J Clin Microbiol 1985; 4: 268-72
16. Bohte R, van Furth R, van den Broek PJ. Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital. Thorax 1995; 50: 543-7
17. Holmberg H. Aetiology of community-acquired pneumonia in hospital-treated patients. Scand J Infect Dis 1987; 19: 491-501
18. Levy M, Dromer F, Brion N, et al. Community-acquired pneumonia: importance of initial noninvasive bacteriologic and radiographic investigations. Chest 1988; 92: 43-8
19. Lieberman D, Schlaeffer F, Boldur I, et al. Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients. Thorax 1996; 51: 179-84
20. Ortqvist A, Hedlund J, Grillner L, et al. Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalisation. Eur Respir J 1990; 3: 1105-13
21. Steinhoff D, Lode H, Ruckdeschel G, et al. Chlamydia pneumoniae as a cause of community-acquired pneumonia in hospitalized patients in Berlin. Clin Infect Dis 1996; 22: 958-64
22. British Thoracic Society Research Committee and the Public Health Laboratory Service. The aetiology, management and outcome of severe community-acquired pneumonia in the intensive care unit. Respir Med 1992; 86: 7-13
23. Moine P, Vercken J-B, Chevret S, et al. Severe community-acquired pneumonia: etiology, epidemiology and prognosis factors. Chest 1994; 105: 1487-95
24. Ortqvist A, Sterner G, Nilsson JA. Severe community-acquired pneumonia: factors influencing need of intensive care treatment and prognosis. Scand J Infect Dis 1985; 17: 377-86
25. Torres A, Serra-Batlles J, Ferrer A, et al. Severe community-acquired pneumonia: epidemiology and prognostic factors. Am Rev Respir Dis 1991; 144: 312-8
26. Woodhead MA, Macfarlane JT, Rodgers FG, et al. Aetiology and outcome of severe community-acquired pneumonia. J Infect 1985; 10: 204-10
27. Sobradillo V, Ansola P, Baranda F, et al. Q fever pneumonia: a review of 164 community-acquired cases in the Basque country. Eur Respir J 1989; 2: 263-6
28. Marrie TJ, Haldane EV, Faulkner RS, et al. The importance of Coxiella burnetii as a cause of pneumonia in Nova Scotia. Can J Publ Health 1985; 76: 233-6
29. Feldman C, Kallenbach JM, Levy H, et al. Community-acquired pneumonia of diverse aetiology: prognostic features in patients admitted to an intensive care unit and a 'severity of illness' score. Intensive Care Med 1989; 15: 302-7
30. Chan CHS, Cohen M, Pang J. A prospective study of community-acquired pneumonia in Hong Kong. Chest 1992; 101: 442-6
31. Alkhaeyer M, Jenkins PF, Harrison BDW. The outcome of community-acquired pneumonia treated on the intensive care unit. Respir Med 1990; 84: 13-6
32. Hirani N, Macfarlane JT. Impact of management guidelines on the outcome of severe community-acquired pneumonia. Thorax 1997; 52: 17-21
33. Sorensen J, Cederholm I, Calrsson C. Pneumonia: a deadly disease despite intensive care treatment. Scand J Infect Dis 1986; 18: 329-35
34. Pachon J, Prados MD, Capote F, et al. Severe community-acquired pneumonia: etiology, prognosis and treatment. Am Rev Respir Dis 1990; 142: 369-73
35. Leroy O, Santre C, Beuscart C, et al. A five year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Intensive Care Med 1995; 21: 24-31
36. Torres A, Dorea J, Zalacain R, et al. Community-acquired pneumonia in chronic obstructive pulmonary disease: a Spanish multicentre study. Am J Respir Crit Care Med 1996; 154: 1456-61
37. Venkatesan P, Gladman J, Macfarlane JT, et al. A hospital study of community-acquired pneumonia in the elderly. Thorax 1990; 45: 254-8
38. Bourke SJ, Lightfoot NF. Chlamydia pneumoniae: defining the clinical spectrum of infection requires precise laboratory diagnosis. Thorax 1995; 50 Suppl. 1: S43-8
39. Levy H. Hantavirus infection. Curr Opin Infect Dis 1997; 10: 103-8
40. Woodhead MA. Atypical pneumonia. Curr Opin Infect Dis 1997; 10: 101-2
41. Woodhead MA, Arrowsmith J, Chamberlain-Webber R, et al. The value of routine microbial investigation in community-acquired pneumonia. Respir Med 1991; 85: 313-7
42. Manresa F, Dorea J. Needle aspiration techniques in the diagnosis of pneumonia. Thorax 1991; 46: 601-3
43. Farr BM, Sloman AJ, Fisch MJ. Predicting death in patients hospitalised for community-acquired pneumonia. Ann Intern Med 1991; 115: 428-36
44. Karalus NC, Cursons RC, Leng RA, et al. Community-acquired pneumonia: aetiology and prognostic index evaluation. Thorax 1991; 46: 413-8
45. Neill AM, Martin IR, Weir R, et al. Community-acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax 1996; 51: 1010-6
46. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-50
47. Mandell LA, Niederman M. The Canadian community-acquired pneumonia consensus conference group. Can J Infect Dis 1993; 4: 25-8
48. Niederman MD, Low BJ, Campbell GD, et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity and initial antimicrobial therapy. Am Rev Respir Dis 1993; 148: 1418-26
49. Société de Pathologie Infectieuse de Langue Française. Infections des voies respiratoires: conférence de concensus en thérapeutique anti-infectieuse. Rev Med Infect 1991; 21: 1s-8s
50. British Thoracic Society. Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. Br J Hosp Med 1993; 49: 349-50
51. SEPAR (Spanish Thoracic Society). National recommendations for diagnosis and treatment of community acquired pneumonia. Barcelona: Ediciones Doyma SA , 1992
52. Pallares R, Linares J, Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995; 333: 474-80
53. Drusano G. Pharmacology of anti-infective agents. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. Chap 14. New York: Churchill Livingstone, 1995: 225-33
54. Johnson AP, Speller DCE, George RC, et al. Prevalence of antibiotic resistance and serotypes in pneumococci in England and Wales: results of observational surveys in 1990 and 1995. BMJ 1996; 312: 1454-6
55. Committee on Safety of Medicines. Current Problems. Curr Probl Pharmacovig 1996; 21: 6
56. Woodhead MA, Radvan J, Macfarlane JT. Adult community-acquired staphylococcal pneumonia in the antibiotic era: a review of 61 cases. Q J Med 1987; 64: 783-90
57. Gialdroni Grassi G, Brumpt I. Sparfloxacin empirical therapy in community-acquired pneumonia: results of a meta-analysis of 2 comparative studies. Drugs 1995; 49 Suppl. 2: 406-8
58. Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med 1995; 333: 1618-24
59. Weingarten SR, Riedinger MS, Varis G, et al. Identification of low-risk hospitalised patients with pneumonia: implications for early conversion to oral antimicrobial therapy. Chest 1994; 105: 1109-15
60. Ramirez JA, Srinath L, Ahkee S, et al. Early switch from intravenous to oral cephalosporins in the treatment of hospitalised patients with community-acquired pneumonia. Arch Intern Med 1995; 155: 1273-6
61. Macfarlane JT, Miller AC, Smith WHR, et al. Comparative radiographic features of community-acquired legionnaires' disease, pneumococcal pneumonia, mycoplasma pneumonia and psittacosis. Thorax 1984; 39: 28-33
62. Holmberg H, Kragsbjerg P. Association of pneumonia and lung cancer: the value of convalescent chest radiography and follow up. Scand J Infect Dis 1993; 25: 93-100